Related Experiment Video
Updated: Oct 18, 2025
06:47
Isolation of Mesenchymal Stem Cells from Human Alveolar Periosteum and Effects of Vitamin D on Osteogenic Activity of Periosteum-derived Cells
Published on: May 4, 2018
9.5K
Spironolactone Attenuates Methylglyoxal-induced Cellular Dysfunction in MC3T3-E1 Osteoblastic Cells
So Young Park1, Kwang Sik Suh2, Woon-Won Jung3
1Department of Endocrinology and Metabolism, Kyung Hee University Hospital, Seoul, Korea.
Journal of Korean Medical Science
|October 5, 2021
Summary
Spironolactone protects osteoblastic cells from methylglyoxal (MG) damage by reducing oxidative stress and inflammation. This study shows spironolactone improves mitochondrial function and bone formation, offering potential therapeutic benefits for related diseases.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Methylglyoxal (MG) contributes to age- and diabetes-related diseases.
- Spironolactone is a known aldosterone antagonist used for hypertension and heart failure.
Purpose of the Study:
- To investigate spironolactone's protective effects against MG-induced cellular dysfunction in MC3T3-E1 osteoblastic cells.
Main Methods:
- MC3T3-E1 cells were exposed to MG with or without spironolactone.
- Assessed mitochondrial function, bone formation, oxidative stress markers, inflammatory cytokines, glyoxalase I, and glutathione (GSH).
Main Results:
- Spironolactone prevented MG-induced cell death and enhanced bone formation.
- Reduced MG-induced endoplasmic reticulum stress, reactive oxygen species, mitochondrial superoxides, and inflammation.
- Increased GSH levels and glyoxalase I activity, improving mitochondrial function and biogenesis markers.
Conclusions:
- Spironolactone mitigates MG-induced cytotoxicity in osteoblasts by decreasing oxidative stress.
- Mechanisms include inhibiting advanced glycation end-product formation, restoring mitochondrial health, and exerting anti-inflammatory effects.
